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UGDH (OMIM603370) encodes an oxidoreductase that converts UDP-glucose to UDP-glucuronate, used in glycosaminoglycans biosynthesis. UGDH knockout leads to severe, but distinct developmental abnormalities in several animal models; however no germline mutation has been reported in human yet.
Using patients' fibroblasts harboring the p.Ala82Thr mutation, we show that it does not alter UGDH mRNA expression, but that its protein level is decreased relative to control cells. Biochemically, UGDHA82T was unable to form hexamers like UGDHWT and was more prone to proteolysis. Consistently, NADH enzymatic reduction by UGDHA82T was significantly decreased relative to UGDHWT.
To confirm the A82T pathogenicity in vivo, we performed rescue experiments using jekyll zebrafish embryos that carry a mutation in the ugdh gene. Interestingly, ugdhWT mRNA injection was able to fully rescue the jekyll phenotype, while ugdhA82T mRNA injection failed to do so.
In the brain, hyaluronan is the major glycosaminoglycan of the extracellular matrix and its deficiency in mice leads to altered neuronal activity and seizures. We thus hypothesize that a deficiency in UGDH activity might give rise to a deficit in hyaluronan production in the developing brain, which could explain the phenotypes of this hitherto undescribed syndrome. Diabetes mellitus is a group of chronic metabolic disorders characterized by inappropriate hyperglycemia. It has been estimated that this disease will affect 7.8% of the world adult population by 2030. Diabetic cardiomyopathy is the leading cause contributing to the increased morbidity and mortality in diabetic patients. Endothelial dysfunction has been reported in diabetic animal models and patients to induce cardiac remodeling and dysfunction. However, the mechanisms by which hyperglycemia induces endothelial dysfunction are not fully understood and currently no specific therapy is available. We and others have demonstrated the cardioprotective role of follistatin-like 1 (FSTL1) under various pathological stresses, including excessive nitric oxide, myocardial infarction, ischemic reperfusion, and pressure overload. However, whether FSTL1 mediates cytoprotection against hyperglycemia-induced endothelial dysfunction remains to be further elucidated. Human umbilical vein endothelial cells (HUVECs) were cultured in endothelial growth medium-2 (EGM-2) (normal glucose, NG). In the high glucose (HG)-treated group, cells were incubated with EBM-2 containing an extra 25 mM of D-glucose. We demonstrated that FSTL1 treatment significantly attenuates hyperglycemia-induced tube formation and migration disability of endothelial cells. Our study provides novel insights into the cardioprotective role of FSTL1 on hyperglycemiainduced endothelial dysfunction. Liver fibrosis is the scarring process that represents the liver's intrinsic response to injury. This gradual scarring of the liver puts people at risk to develop liver cirrhosis and liver cancer. We have identified several patients from two families with chronic liver fibrosis that is caused by homozygous loss of function mutations in a Protein Disulfide Isomerase (PDI). This family of enzymes resides in the endoplasmic reticulum (ER) and is important for the proper folding of proteins via disulfide bridging. Mutation from one family results in a protein null while the other results in loss of PDI enzymatic activity. Characterization of patient fibroblasts show elevated expression of ER stress genes. Loss of PDI activity is known to cause protein misfolding. Accumulation of misfolded proteins can activate the ER stress mechanism which aims to restore ER homeostasis or initiate cell death. This PDI is expressed in both hepatocytes and hepatic stellate cells in the human liver. Knockdown of PDI in immortalized hepatocytes increases the expression of ER stress genes. Previous studies have implicated ER stress in contributing to fibrosis. Together, our data suggests that increased ER stress may be a mechanism that contributes to the initiation and progression of liver fibrosis. Robinow Syndrome is characterized by 'fetal facies' and is caused by mutations in the WNT5A ligand, the adaptor protein DVL or the receptor ROR2. Patients typically have a wider midface which suggests that embryonic facial narrowing was disrupted. In order to model Robinow syndrome we inserted mutant genes into the chicken embryo face. We knocked in C-terminal nonsense mutations into human Dishevelled 1 that cause autosomal dominant Robinow Syndrome (DRS2, OMIM 616331). Either wild-type or mutant DVL1 constructs were cloned into RCAS retroviruses and injected into the stage 15 frontonasal mass. External phenotypes: by stage 29-30 the egg tooth formed in all embryos indicating that epithelialmesenchymal interactions were unaffected. The frontonasal mass was broader than normal and shorter in sagittal plane (8/12). At stage 38, there was significant upper beak shortening for 1519ΔT, 1529ΔG (6/7 and 13/14). In contrast, the wtDVL1 embryos had mild deviations (9/25) or were normal (15/25). Molecular results: There were no changes in proliferation 48h post-infection. However, there were many changes in gene expression at 48h that were specific to mutant DLV1. AXIN2, LEF1, BMP2, SOX9 and ROR2, WNT5A, Prickle, ALX1 and ALX4 were downregulated in DVL1
1519ΔT infected embryos.
In contrast, ROR2, SOX9 and VANGL2 were increased in wtDVL1. These gene differences reduce the likelihood that phenotypes are only due to having higher levels of DVL1. Based on biochemical data from others, the loss of the C terminal leads to a conformational change in DVL1 protein which could explain the downstream signaling effects. Winchester syndrome is a rare, autosomal recessive congenital disorder caused by deleterious mutations in MMP14, a membranebound metalloprotease. Severity of the phenotype varies, but patients typically have stunted growth, abnormal ossification of cranial sutures and drastically reduced bone density leading to pervasive deformity. They usually succumb prior to puberty to the cardiac defects that may be associated, such as mitral valve insufficiency.
The reasons for the reduced bone density are insufficiently understood and treatment therefore is a hit-and-miss affair. We have now generated a zebrafish model that recapitulates the bone defects in Winchester syndrome. We expect that it will be a valuable tool for developing novel treatments for this devastating disorder. Congenital defects, such as facial malformations and cleft lip/palate, affect up to 4% of live births annually. The aetiology of these defects is poorly understood due to the complex nature of craniofacial development. Our lab focuses on the highly conserved Grainyhead-like (Grhl) family of transcription factors, of which Grhl3 is implicated in palatal clefts in humans. Our aim is to characterise the role of these genes in the facial primordia, particularly family member Grhl2, whose influence on craniofacial development remains uncharacterised.
Numerous Grhl2-null mouse models show severe craniofacial defects, including clefts. Our data show that mice lacking Grhl2 display a disrupted oral epithelium, altered epithelial-mesenchymal marker expression and a hypomorphic maxillary prominence. As Grhl2-/-mice are embryonic lethal by E11.5, precluding palatal closure, we have optimised a palate culture technique that enables growth of dissected palate tissue, from an earlier stage than previously described (E10.5). This allows direct examination of the effect Grhl2 loss has on palate formation; our data using this technique confirms a tissue-specific requirement for Grhl2 function in palatogenesis, as well as recapitulating the epithelial defects seen in Grhl2-/-embryos in vivo.
Using an approach that combines RNA-seq data and candidate target gene discovery, our lab has uncovered a novel signalling pathway regulating craniofacial development that involves interactions between Grhl2 and the Bone Morphogenetic Protein (BMP)-family antagonist Noggin. Following Grhl2 deletion, Noggin is significantly upregulated within the maxillary prominence, with subsequent repression of BMP signalling within the developing craniofacial primordia. As BMPmediated signalling plays important roles in facial tissue patterning/ development, this loss-of-function leads to disrupted palate formation. Our current and future goals are to firstly confirm this novel relationship through genetic deletion models, and secondly, to ameliorate the severity of the palatal phenotype through provision of exogenous small molecules, such as BMP, to our palate explants. Heterotaxy is a congenital abnormality where thoraco-abdominal organs demonstrate abnormal arrangement across the left-right axis of the body, affecting their placement and orientation. The leftright axis is established early in embryogenesis when unidirectional signals emanate from the node at the midline to initiate distinct molecular pathways on the left and right sides of the developing embryo. The gene most commonly mutated in human cases of Heterotaxy is the X-linked ZIC3, but the mechanism by which the ZIC3 transcription factor prevents Heterotaxy remains unknown. A genetic screen for mutations that affect murine embryogenesis identified a novel null allele of Zic3, called katun (Ka). The mutant embryos exhibit Heterotaxy and also incompletely penetrant, partial (posterior) axis duplications and anterior truncation. These latter two phenotypes are redolent of elevated canonical Wnt signalling.
ZIC3 is a member of the Zic family of transcriptional regulators and previous work has shown that the ZICs can interact with TCF proteins to inhibit Wnt/β-catenin mediated transcription when overexpressed in cell lines. Additionally, analysis of Ka and Tcf7l1 -/ -embryos reveals similar ectopic expression of Foxa2, a direct target of Wnt/β-catenin mediated transcription. This raises the possibility that ZIC3 directly interacts with TCF7L1 to repress the expression of Wnt target genes during gastrulation and consequently, dysregulated Wnt signalling may contribute to Heterotaxy. Via analysis of the murine batface (Bfc) gain-of-function allele of β-catenin that results in elevated Wnt/β-catenin signalling, we have shown that Bfc recapitulates the ectopic expression of Foxa2 seen in Ka mutants. Furthermore, the node of both Ka and Bfc homozygous embryos is misshapen with patches of non-ciliated cells that express endoderm genes. Moreover we find that human ZIC3-Heterotaxy associated
